New sleep drug shows promise in early trial
NCT ID NCT06956495
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new drug called tasipimidine can help people with insomnia fall asleep faster and stay asleep longer. 190 adults with chronic insomnia took either the drug or a placebo for 3 nights in a sleep clinic, with some continuing for 4 more weeks at home. Researchers measured sleep quality using brain-wave recordings and sleep diaries to see if the drug works better than a dummy pill.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Terveystalo Helsinki Uniklinikka
Helsinki, 00380, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light therapy during sleep may offer a Drug-Free path to better rest
- Mind over bladder: can sleep training curb nighttime urges?
- Can an ancient herbal formula unlock better sleep and weight loss?
- Could a simple sleep guide ease insomnia in lung disease?
- Digital sleep coaching for seniors: a new hope for insomnia?
- Fixing sleep, fortifying hearts: a new trial tests the link